http://ifttt.com/images/no_image_card.png The platelet function substudy of the TRILOGY-ACS trial shows that there is no significant difference between prasugrel and clopidogrel in cardiovascular mortality, myocardial infarction, or stroke outcomes.
Read more...
Read more...
No comments:
Post a Comment